PharmaMedic /
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
PharmaMedic
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us

Posts navigation

Previous 1 … 8 9 10 … 15 Next
ATMPs for rare diseases a priority for Innovative Health Initiative funding

ATMPs for rare diseases a priority for Innovative Health Initiative funding

Research themes under consideration for the next round of Innovative Health Initiative (IHI) funding include Topic 4: Strengthening the European translational research ecosystem for advanced therapy medicinal products (ATMPs) for rare diseases.

5 Dec 2022
Read More
Challenges and Trends in Medical Affairs

Challenges and Trends in Medical Affairs

Medical affairs is an increasingly complex discipline. It is vital that the team is highly trained and able to adapt to an evolving environment, liaising effectively with stakeholders to communicate value and bring new treatments to the market. Read on to discover some of the challenges and trends affecting the sector.

30 Nov 2022
Read More
UK government introduces Vaccine Taskforce model to tackle four health challenges

UK government introduces Vaccine Taskforce model to tackle four health challenges

A fund of over £113 million has been announced today (28 November 2022) to develop innovative medicines and diagnostics for cancer, obesity, mental health and addiction in the UK population.

28 Nov 2022
Read More
European Union’s share of global medicine R&D shrinks by 25% in 20 years

European Union’s share of global medicine R&D shrinks by 25% in 20 years

A report commissioned by the European Federation of Pharmaceutical Industries and Associations (EFPIA) has led the organisation to warn that the options being discussed by policymakers around the EU Pharma Strategy fall short.

25 Nov 2022
Read More
UK Autumn Statement to review life sciences regulation

UK Autumn Statement to review life sciences regulation

Among the measures unveiled in the UK government’s Autumn Statement, published on 17 November 2022, Chancellor of the Exchequer Jeremy Hunt said that there will be regulatory reform to encourage economic growth in key industries, including the life sciences.

22 Nov 2022
Read More
Trends Affecting Pharmacovigilance

Trends Affecting Pharmacovigilance

Pharmacovigilance (PV) – the proactive maintenance of drug safety through collection, detection, assessment, monitoring and prevention of adverse effects – has been evolving since the first concerns were raised over the negative effects of chloroform anaesthetic in the 1800s. Today, it is just as important that pharma, start-ups and regulators keep up to date with the latest trends to ensure that drugs are safe and monitoring practices remain fit for purpose.

21 Nov 2022
Read More
MHRA postpones implementation of Medical Device Regulations

MHRA postpones implementation of Medical Device Regulations

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has announced a 12-month extension to its substantial reform of the Medical Device Regulations, which will now come into force by July 2024.

14 Nov 2022
Read More
MHRA fast-tracks pill to prevent pre-eclampsia

MHRA fast-tracks pill to prevent pre-eclampsia

Scientists at MirZyme Therapeutics believe they have developed a drug that, when given to women from 20 weeks of pregnancy, could stop them developing the condition.

9 Nov 2022
Read More
MHRA and NICE get Wellcome funding for regulation of mental health products

MHRA and NICE get Wellcome funding for regulation of mental health products

Wellcome has awarded £1.8m to the Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) so that they can investigate and produce guidance on regulation of digital mental health tools.  

7 Nov 2022
Read More
Trade bodies unite to support better access to vaccines for future pandemics

Trade bodies unite to support better access to vaccines for future pandemics

The Biotechnology Innovation Organisation (BIO), Developing Countries Vaccine Manufacturers’ Network (DCVMN) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) met at the ‘Global Equity & Timely Access: COVID-19 and Beyond’ meeting in India in October and announced their support for the Berlin Declaration ‘biopharmaceutical industry vision for equitable access in pandemics’.

3 Nov 2022
Read More

Posts navigation

Previous 1 … 8 9 10 … 15 Next

Categories

  • Awards
  • Consultants
  • Events
  • News
    • General
    • Medical Affairs
    • Rare diseases
  • Our Services
  • Regulatory
  • Resources
    • White Paper

Tags

#ABPI #BIA #cancer #ClinicalTrials #drugapprovals #drugpricing #drugregulation #EC #EFPIA #EMA #EU #FDA #HorizonEurope #HTA #innovation #lifesciences #marketaccess #MDR #medicalaffairs #medicaldevice #medicinesaccess #medtech #mentalhealth #mhra #NHS #NICE #patients #pharmaregulation #pre-eclampsia #R&D #rarediseases #regulation #regulatory #research #startups #UKgovernment #ukpharma #ukregulation #VPAS AI Biotech COVID-19 Healthcare medicaldevices Pharma
PharmaMedic
  • Home
  • Join Us
  • Our Vision
  • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
Our Services
  • Start-Up
  • Product Launch
  • Product Development
Legal
  • Privacy Policy
  • Cookie Policy
Contact us
  • T:+44 (0) 208 168 1668
  • US Toll Free:+1 628 201 0911
  • [javascript protected email address]
  • The London Bioscience Innovation Centre (LBIC)
    2 Royal College Street
    London NW1 0NH

©2023 PharmaMedic. All Rights Reserved | Company Registration Number: 07364364 | VAT: 135986768

Powered by FL1 Digital